On July 1, 2026, Georgia’s medical cannabis program was expanded following the approval of Senate Bill 220 – introducing vaporization formats for patients aged over 21, removing the restrictive 5% product potency cap, and significantly easing patient access.
Read more ›
Since the start of medical cannabis sales in March 2020, Utah’s quarterly net sales revenue from medical cannabis products has consistently grown and is on track to total close to $200 million for the whole of 2026.
Read more ›
In Rhode Island, cannabis licenses are available for cultivation, product manufacturing, retail, and testing. A new license application process for the 24 available adult-use cannabis retailer licenses will open by August 10, 2026.
Read more ›
Since adult-use legalization, Rhode Island’s total cannabis sales have brought in about $414 million with adult-use sales accounting for nearly 80%.
Read more ›
Two states, Idaho and Massachusetts, will have their cannabis reform measures on the 2026 ballot, scheduled to be held on November 3.
Read more ›
Nebraska’s regulations for the state’s medical cannabis market establish four license types: cultivator, product manufacturer, dispensary, and transporter.
Read more ›
On November 5, 2024, Nebraska became the 41st state to legalize medical cannabis. With the first state-licensed cultivator approved in June 2026 to start planting cannabis, the state is advancing towards launching a fully operational medical cannabis market.
Read more ›
The state budget was signed into law on June 29, 2026, officially legalizing the framework for creating a regulated adult-use cannabis market in Virginia – which according to some estimates could be worth up to $3 billion. Sales are scheduled to start on July 1, 2027.
Read more ›
Main steps in short: Understand regulatory and legal requirements. Do market research. Decide on the type of cannabis business. Choose […]
Read more ›
In 2025, total sales reached approximately $60 million, representing an 82% year-over-year increase from 2024. This surge underscores the accelerating growth of Washington, D.C.’s medical cannabis program.
Read more ›Categories
- Cannabis Business
- Cannabis Markets
- Cannabis Africa
- Cannabis Canada
- Cannabis Europe
- Cannabis Latin America and the Caribbean
- Cannabis Oceania
- Cannabis US
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- DC
- Delaware
- Florida
- Georgia
- Guam
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Puerto Rico
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virgin Islands
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
- Hemp Industry